Dilantin (Page 7 of 7)
PRINCIPAL DISPLAY PANEL — 30 mg Capsule Bottle Label
ALWAYS DISPENSE WITH ACCOMPANYING MEDICATION GUIDE
Pfizer
NDC 0071-3740-66
Dilantin ®
(extended phenytoinsodium capsules, USP)
30 mg
100 Capsules
Rx only
PRINCIPAL DISPLAY PANEL — 100 mg Capsule Bottle Label
ALWAYS DISPENSE WITH ACCOMPANYING MEDICATION GUIDE
Pfizer
NDC 0071-0369-24
Dilantin ®
(extended phenytoinsodium capsules, USP)
100 mg
100 Capsules
Rx only
PRINCIPAL DISPLAY PANEL — 100 mg Capsule Blister Pack
Dilantin ®
(phenytoin sodium)
Extended Oral Capsule
100 mg
Protect From
Light and Moisture.
DIST BY PARKE-DAVISDIV OF PFIZER INC, NY, NY 10017
LOT AREA & EXP
PRINCIPAL DISPLAY PANEL — 100 mg Capsule Blister Pack Carton
UNIT DOSE
ALWAYS DISPENSE WITH ACCOMPANYING MEDICATION GUIDE
Pfizer
NDC 0071-0369-40
Dilantin ® (extended phenytoin sodium capsules, USP)
100 mg
For in-institution use only
100 Capsules
Rx only
DILANTIN extended phenytoin sodium capsule | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
DILANTIN extended phenytoin sodium capsule | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
|
Labeler — Parke-Davis Div of Pfizer Inc (829076962) |
Registrant — Pfizer Inc (113480771) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Pharmacia & Upjohn Company LLC | 618054084 | ANALYSIS (0071-0369), ANALYSIS (0071-3740), API MANUFACTURE (0071-0369), API MANUFACTURE (0071-3740) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Pfizer Pharmaceuticals LLC | 829084552 | ANALYSIS (0071-0369), ANALYSIS (0071-3740), MANUFACTURE (0071-0369), MANUFACTURE (0071-3740), PACK (0071-0369), PACK (0071-3740), LABEL (0071-0369), LABEL (0071-3740) |
Revised: 03/2022 Parke-Davis Div of Pfizer Inc
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.